$CNFN
CFN Enterprises Inc. Stock $cnfn

$cnfn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000109690624000789 Filed on April 11, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$5.894M	$1.594M	$3.538M
YoY Change	3769.94%	226.02%	-18.06%
Cost Of Revenue	$4.878M	$1.574M	$3.023M
YoY Change	10172.94%	96.37%	-53.58%
Gross Profit	$1.016M	$20.07K	$514.7K
YoY Change	869.27%	-106.42%	-123.45%
Gross Profit Margin	17.24%	1.26%	14.55%
Selling, General & Admin	$1.547M	$1.908M	$5.631M
YoY Change	-9.17%	123.69%	113.14%
% of Gross Profit	152.26%	9506.58%	1094.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.478K	$8.430K	$59.43K
YoY Change	234.79%	-97.91%	-96.31%
% of Gross Profit	0.93%	42.0%	11.55%
Operating Expenses	$1.547M	$1.908M	$14.31M
YoY Change	-9.17%	123.68%	132.34%
Operating Profit	-$531.0K	-$1.888M	-$13.79M
YoY Change	-66.78%	61.98%	63.18%
Interest Expense	$720.4K	-$762.1K	$1.632M
YoY Change	1823.7%	77.66%	134.97%
% of Operating Profit
Other Income/Expense, Net	-$720.4K	$22.15K	-$1.394M
YoY Change	-605.14%	-27.21%	-5.14%
Pretax Income	-$1.251M	-$11.27M	-$15.19M
YoY Change	-14.04%	86.85%	53.06%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.251M	-$11.33M	-$15.19M
YoY Change	-14.04%	86.62%	52.95%
Net Earnings / Revenue	-21.23%	-710.84%	-429.29%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.14	-$0.25
COMMON SHARES
Basic Shares Outstanding	82.21M shares	82.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$225.4K	$78.74K	$78.74K
YoY Change	-78.49%	531.44%	531.44%
Cash & Equivalents	$225.4K	$78.74K
Short-Term Investments
Other Short-Term Assets	$20.60K	$20.45K	$20.45K
YoY Change	1.58%	1.59%	1.59%
Inventory	$1.865M	$1.796M	$1.796M
Prepaid Expenses
Receivables	$1.701M	$942.2K	$942.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.811M	$2.838M	$2.838M
YoY Change	245.06%	4563.61%	4563.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.4K	$156.3K	$2.315M
YoY Change	243.19%	191.85%	1312.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$297.3K	$297.3K	$297.3K
YoY Change
Other Assets	$8.810K	$8.910K	$8.910K
YoY Change	-84.18%	-98.62%	-98.62%
Total Long-Term Assets	$6.142M	$5.459M	$2.622M
YoY Change	315.92%	527.1%	223.77%
TOTAL ASSETS
Total Short-Term Assets	$3.811M	$2.838M	$2.838M
Total Long-Term Assets	$6.142M	$5.459M	$2.622M
Total Assets	$6.142M	$5.459M	$5.459M
YoY Change	315.92%	527.1%	527.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.440M	$3.019M	$3.019M
YoY Change	91.54%	28.03%	28.03%
Accrued Expenses	$5.530M	$3.828M	$4.650M
YoY Change	126.92%	63.34%	78.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.362M	$7.272M	$7.272M
YoY Change	94.01%	135.48%	135.48%
Total Short-Term Liabilities	$19.75M	$17.21M	$17.21M
YoY Change	108.8%	94.21%	94.21%
LONG-TERM LIABILITIES
Long-Term Debt	$127.0K	$128.4K	$128.4K
YoY Change	-82.98%	-86.87%	-86.87%
Other Long-Term Liabilities	$1.584M	$1.547M	$1.547M
YoY Change	607.81%	670.78%	670.78%
Total Long-Term Liabilities	$127.0K	$128.4K	$1.676M
YoY Change	-82.98%	-86.87%	42.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.75M	$17.21M	$17.21M
Total Long-Term Liabilities	$127.0K	$128.4K	$1.676M
Total Liabilities	$21.46M	$18.89M	$18.89M
YoY Change	105.79%	88.1%	88.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.44M	-$74.42M
YoY Change	25.06%	26.15%
Common Stock	$82.21K	$82.21K
YoY Change	97.1%	118.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$15.32M	-$13.43M	-$13.43M
YoY Change
Total Liabilities & Shareholders Equity	$6.142M	$5.459M	$5.459M
YoY Change	315.92%	527.1%	527.1%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.251M	-$11.33M	-$15.19M
YoY Change	-14.04%	86.62%	52.95%
Depreciation, Depletion And Amortization	$9.478K	$8.430K	$59.43K
YoY Change	234.79%	-97.91%	-96.31%
Cash From Operating Activities	$75.26K	-$1.213M	-$4.979M
YoY Change	242.09%	3779.18%	250.91%
INVESTING ACTIVITIES
Capital Expenditures	$19.27K	$0.00	$162.2K
YoY Change		-100.0%	-52.25%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$742.4K
YoY Change	-100.0%
Cash From Investing Activities	-$19.27K	$0.00	$580.2K
YoY Change	-103.17%	-100.0%	-270.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$350.0K
YoY Change			-14.63%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	16.45K	-449.2K	$4.465M
YoY Change	-95.88%	-405.28%	178.9%
NET CHANGE
Cash From Operating Activities	75.26K	-1.213M	-$4.979M
Cash From Investing Activities	-19.27K	0.000	$580.2K
Cash From Financing Activities	16.45K	-449.2K	$4.465M
Net Change In Cash	72.44K	-1.662M	$66.59K
YoY Change	-92.96%	1627.66%	-142.3%
FREE CASH FLOW
Cash From Operating Activities	$75.26K	-$1.213M	-$4.979M
Capital Expenditures	$19.27K	$0.00	$162.2K
Free Cash Flow	$55.99K	-$1.213M	-$5.141M
YoY Change	154.5%	398.49%	192.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-52635
CY2023	dei	Entity Registrant Name EntityRegistrantName	CFN ENTERPRISES INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1559541
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	600 E. 8th STREET
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	WHITEFISH
CY2023	dei	Entity Address Country EntityAddressCountry	MT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59937
CY2023	dei	City Area Code CityAreaCode	(833)
CY2023	dei	Local Phone Number LocalPhoneNumber	420-2636
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2711950	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82210664	shares
CY2023	dei	Auditor Name AuditorName	RBSM LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023	dei	Auditor Firm AuditorFirmId	587
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78744	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20448	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	20128	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	942248	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28245	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1796227	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	0	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2837667	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	60847	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156343	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53570	usd
CY2023Q4	fil	Right Of Use Asset RightOfUseAsset	2159043	usd
CY2022Q4	fil	Right Of Use Asset RightOfUseAsset	110321	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	297269	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	0	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	8910	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	46766	usd
CY2023Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5459232	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	870551	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3018531	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2357614	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3828063	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2343654	usd
CY2023Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	0	usd
CY2022Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	217500	usd
CY2023Q4	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2022Q4	fil	Due To Related Party DueToRelatedParty	503259	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	484212	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10978	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7272357	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3088250	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	208000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	0	usd
CY2023Q4	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	822259	usd
CY2022Q4	fil	Current Portion Of Right Of Use Liability CurrentPortionOfRightOfUseLiability	262727	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	79823	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17214385	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8863805	usd
CY2023Q4	fil	Right Of Use Liability RightOfUseLiability	1547410	usd
CY2022Q4	fil	Right Of Use Liability RightOfUseLiability	200758	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	128443	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	978337	usd
CY2023Q4	us-gaap	Liabilities Liabilities	18890238	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10042900	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82210664	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82210664	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37609664	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37609664	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	82210	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37690	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60909641	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49786056	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74422861	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58996099	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13431006	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9172349	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5459232	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	870551	usd
CY2023	us-gaap	Revenues Revenues	3537632	usd
CY2022	us-gaap	Revenues Revenues	4317490	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3022942	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	6512109	usd
CY2023	us-gaap	Gross Profit GrossProfit	514690	usd
CY2022	us-gaap	Gross Profit GrossProfit	-2194619	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8676430	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3615961	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5630794	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2641842	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14307224	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6257803	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-13792534	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-8452422	usd
CY2023	us-gaap	Interest Expense InterestExpense	1631564	usd
CY2022	us-gaap	Interest Expense InterestExpense	694380	usd
CY2023	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	0	usd
CY2022	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	-563220	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-46516	usd
CY2023	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-200000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	48112	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Other Income OtherIncome	179650	usd
CY2022	us-gaap	Other Income OtherIncome	34206	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	321	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	113	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1394228	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1469797	usd
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-15186762	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-9922219	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2023	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-15426762	usd
CY2022	fil	Net Loss Available To Common Shareholders NetLossAvailableToCommonShareholders	-10162219	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-19826	usd
CY2023	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-15426762	usd
CY2022	fil	Net Loss Available To Cfn Enterprises Common Shareholders NetLossAvailableToCfnEnterprisesCommonShareholders	-10142393	usd
CY2023	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.25
CY2022	fil	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.3
CY2023	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	61232637	shares
CY2022	fil	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	34258898	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395743	usd
CY2022	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2022	fil	Issuance Of Common Stock For Proceeds IssuanceOfCommonStockForProceeds	1050019	usd
CY2022	fil	Shares Issued Pursuant To Conversion Of Debt2 Value SharesIssuedPursuantToConversionOfDebt2Value	1308060	usd
CY2022	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	32000	usd
CY2022	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9929222	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9172349	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	600000	usd
CY2023	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	450000	usd
CY2023	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1156100	usd
CY2023	fil	Warrants Issued In Connection With Note Payable WarrantsIssuedInConnectionWithNotePayable	811861	usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	150144	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	240000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-15186762	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13431006	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-15186762	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-9922219	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59427	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1612332	usd
CY2023	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	411200	usd
CY2022	fil	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	553254	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8676430	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	356349	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	180398	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	178721	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	305081	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1156100	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9253	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	48112	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	fil	Loss On Conversion Of Debt LossOnConversionOfDebt	0	usd
CY2022	fil	Loss On Conversion Of Debt LossOnConversionOfDebt	563220	usd
CY2023	fil	Impairment Charge On Right Of Use Asset ImpairmentChargeOnRightOfUseAsset	0	usd
CY2022	fil	Impairment Charge On Right Of Use Asset ImpairmentChargeOnRightOfUseAsset	3615961	usd
CY2023	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-200000	usd
CY2023	fil	Unrealized Gain Loss On Marketable Securities UnrealizedGainLossOnMarketableSecurities	0	usd
CY2022	fil	Unrealized Gain Loss On Marketable Securities UnrealizedGainLossOnMarketableSecurities	46516	usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-19826	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1095012	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-66372	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1796227	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-157706	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37856	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-110365	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2355008	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1266789	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	473234	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-28846	usd
CY2023	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	32500	usd
CY2022	fil	Payments Made In Advance Of Securities Date PaymentsMadeInAdvanceOfSecuritiesDate	217500	usd
CY2023	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-580407	usd
CY2022	fil	Increase Decrease In Right Of Use Liability IncreaseDecreaseInRightOfUseLiability	-210709	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4978948	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1418850	usd
CY2023	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	134060	usd
CY2022	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	0	usd
CY2023	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-608300	usd
CY2022	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	0	usd
CY2023	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	-162200	usd
CY2022	fil	Purchase Of Property And Equipment Net PurchaseOfPropertyAndEquipmentNet	-339655	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	580160	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-339655	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2119	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	7995	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5000000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1233000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1032647	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	49917	usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	150144	usd
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	350000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	410000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4465378	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1601078	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	66590	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-157427	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32602	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190029	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99192	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32602	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170015	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	20128	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	20014	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	32602	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	190029	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78744	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12474	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	20448	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	20128	usd
CY2023Q4	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	99192	usd
CY2022Q4	fil	Cash And Restricted Cash At End Of Period CashAndRestrictedCashAtEndOfPeriod	32602	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	us-gaap	Interest Paid InterestPaid	0	usd
CY2023	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2022	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	0	usd
CY2023	fil	Due To Seller And Contingent Consideration Pursuant To Business Combination DueToSellerAndContingentConsiderationPursuantToBusinessCombination	1208000	usd
CY2022	fil	Due To Seller And Contingent Consideration Pursuant To Business Combination DueToSellerAndContingentConsiderationPursuantToBusinessCombination	0	usd
CY2023	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	450000	usd
CY2022	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	0	usd
CY2023	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	187863	usd
CY2022	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	0	usd
CY2023	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	811861	usd
CY2022	fil	Warrants Issued With Promissory Notes WarrantsIssuedWithPromissoryNotes	302537	usd
CY2023	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	120000	usd
CY2022	fil	Accrual Of Preferred Stock Interest AccrualOfPreferredStockInterest	240000	usd
CY2023	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	0	usd
CY2022	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2023	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	0	usd
CY2022	fil	Purchase Of Property And Equipment With Accounts And Notes Payable PurchaseOfPropertyAndEquipmentWithAccountsAndNotesPayable	55016	usd
CY2023	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	0	usd
CY2022	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	212067	usd
CY2019Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
CY2023Q4	fil	Working Capital Deficit WorkingCapitalDeficit	14376718	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74422861	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15186762	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><b><i>Use of Estimates</i></b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, impairment of long-lived assets, borrowing rate considered for operating lease right-of-use asset and related operating lease liability, and assumptions used in Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	796251	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	470532	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	356349	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	180398	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1796227	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><b><i>Concentration of Credit Risks</i></b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company’s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. From time-to-time, the Company’s bank balances exceed the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><b><i>Concentrations</i></b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company had one customer which accounted for 50% of accounts receivable as of December 31, 2023. During the year ended December 31, 2023, three customers accounted for 74% of the Company’s revenues. The Company may be negatively affected by the loss of one of these customers.</p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Revenues Revenues	3537632	usd
CY2022	us-gaap	Revenues Revenues	4317490	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-200000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	59140	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	40243	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2023Q4	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	208000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	9208000	usd
CY2023Q4	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	134060	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	175340	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	297269	usd
CY2023Q4	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedGoodwill	8676430	usd
CY2023Q4	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Right Of Use Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedRightOfUseAsset	2272059	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	48430	usd
CY2023Q4	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Right Of Use Liability Current BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedRightOfUseLiabilityCurrent	-538243	usd
CY2023Q4	fil	Business Combination Recognized Identifiable Assets Acquired Andliabilities Assumed Right Of Use Liability Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndliabilitiesAssumedRightOfUseLiabilityNoncurrent	-1760485	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	9208000	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5731373	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	6103373	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-15462141	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-9889241	usd
CY2023	fil	Business Acquisition Proforma Earnings Per Share BusinessAcquisitionProformaEarningsPerShare	-0.25
CY2022	fil	Business Acquisition Proforma Earnings Per Share BusinessAcquisitionProformaEarningsPerShare	-0.29
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	226973	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64772	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70630	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11202	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156343	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53570	usd
CY2022Q2	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2022	fil	Settlement Of Accounts Payable With Sale Of Equipment SettlementOfAccountsPayableWithSaleOfEquipment	212067	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	87933	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	3276193	usd
CY2023	us-gaap	Depreciation Depreciation	59428	usd
CY2022	us-gaap	Depreciation Depreciation	1612334	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46516	usd
CY2023	fil	Additions Of Marketable Securities AdditionsOfMarketableSecurities	0	usd
CY2022	fil	Additions Of Marketable Securities AdditionsOfMarketableSecurities	0	usd
CY2023	fil	Sale Of Marketable Securities SaleOfMarketableSecurities	0	usd
CY2023	fil	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	0	usd
CY2022	fil	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	-46516	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2021Q2	us-gaap	Notes Payable NotesPayable	2957000	usd
CY2021Q2	fil	Outstanding Amount OutstandingAmount	158625	usd
CY2021Q2	fil	Balance Paid Per Month BalancePaidPerMonth	20000	usd
CY2021Q2	fil	Total Paid Per Month TotalPaidPerMonth	138625	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	250000	usd
CY2021Q4	fil	Accrued Interest Rate AccruedInterestRate	0.12	pure
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	79823	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	79823	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	100953	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	599047	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	699000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7272357	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8772	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	8772	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	8772	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	102127	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	7400800	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7272357	usd
CY2022Q2	fil	Issuance Of Common Stock For Proceeds IssuanceOfCommonStockForProceeds	800020	usd
CY2023Q4	fil	Purchase Of Property And Equipment With Common Stock PurchaseOfPropertyAndEquipmentWithCommonStock	700000	usd
CY2023	fil	Gain On Conversion GainOnConversion	8000	usd
CY2022Q4	fil	Securities Purchase Agreement Shares SecuritiesPurchaseAgreementShares	800000	shares
CY2022Q4	fil	Proceeds From Securities Purchase Agreement ProceedsFromSecuritiesPurchaseAgreement	200000	usd
CY2023Q4	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	405000	usd
CY2023Q4	fil	Issuance Of Common Stock Pursuant To Business Combination IssuanceOfCommonStockPursuantToBusinessCombination	8000000	usd
CY2023Q4	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	45000	usd
CY2023Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	0	usd
CY2022Q4	fil	Payments In Advance Of Securities Date PaymentsInAdvanceOfSecuritiesDate	217500	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	fil	Shares Issued As Payment For Accrued Interest Value SharesIssuedAsPaymentForAccruedInterestValue	405000	usd
CY2023Q4	fil	Conversion Of Accrued Preferred Stock Interest Into Shares ConversionOfAccruedPreferredStockInterestIntoShares	45000	usd
CY2023	us-gaap	Dividends Paidinkind DividendsPaidinkind	240000	usd
CY2022	us-gaap	Dividends Paidinkind DividendsPaidinkind	240000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1156100	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent	79823	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent	79823	usd
CY2022Q4	fil	Assets Held For Sale Long Lived Fair Value Disclosure Gross AssetsHeldForSaleLongLivedFairValueDisclosureGross	700000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11921729	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7280948	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11921729	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7280948	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.30	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.30	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9513105	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5666600	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	2425236	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	2065027	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11921729	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7280948	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11921729	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7280948	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34000000	usd
CY2023	fil	Right Of Use Asset And Liability RightOfUseAssetAndLiability	187863	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Next Rolling Twelve Months OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths	822259	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	644771	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Three OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree	646193	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Four OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour	398750	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	12662	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2524636	usd
CY2023Q4	fil	Imputed Interest ImputedInterest	-154967	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2369669	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	822259	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1547410	usd
CY2023Q4	fil	Right Of Use Asset RightOfUseAsset	2159043	usd
CY2022Q4	fil	Right Of Use Asset RightOfUseAsset	110321	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	822259	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	262727	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1547410	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	200758	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2369669	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	463485	usd
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2023Q4	fil	Due To Related Party DueToRelatedParty	501140	usd
CY2022Q4	fil	Due To Related Party DueToRelatedParty	503259	usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	150144	usd

Files In Submission

Name	View Source	Status
0001096906-24-000789-index-headers.html	Edgar Link	pending
0001096906-24-000789-index.html	Edgar Link	pending
0001096906-24-000789.txt	Edgar Link	pending
0001096906-24-000789-xbrl.zip	Edgar Link	pending
cfnex10z23_1.jpg	Edgar Link	pending
cfnex10z23_10.jpg	Edgar Link	pending
cfnex10z23_11.jpg	Edgar Link	pending
cfnex10z23_12.jpg	Edgar Link	pending
cfnex10z23_13.jpg	Edgar Link	pending
cfnex10z23_14.jpg	Edgar Link	pending
cfnex10z23_15.jpg	Edgar Link	pending
cfnex10z23_16.jpg	Edgar Link	pending
cfnex10z23_17.jpg	Edgar Link	pending
cfnex10z23_18.jpg	Edgar Link	pending
cfnex10z23_19.jpg	Edgar Link	pending
cfnex10z23_2.jpg	Edgar Link	pending
cfnex10z23_20.jpg	Edgar Link	pending
cfnex10z23_21.jpg	Edgar Link	pending
cfnex10z23_22.jpg	Edgar Link	pending
cfnex10z23_23.jpg	Edgar Link	pending
cfnex10z23_24.jpg	Edgar Link	pending
cfnex10z23_25.jpg	Edgar Link	pending
cfnex10z23_26.jpg	Edgar Link	pending
cfnex10z23_27.jpg	Edgar Link	pending
cfnex10z23_28.jpg	Edgar Link	pending
cfnex10z23_29.jpg	Edgar Link	pending
cfnex10z23_3.jpg	Edgar Link	pending
cfnex10z23_30.jpg	Edgar Link	pending
cfnex10z23_4.jpg	Edgar Link	pending
cfnex10z23_5.jpg	Edgar Link	pending
cfnex10z23_6.jpg	Edgar Link	pending
cfnex10z23_7.jpg	Edgar Link	pending
cfnex10z23_8.jpg	Edgar Link	pending
cfnex10z23_9.jpg	Edgar Link	pending
cfn_ex10z23.htm	Edgar Link	pending
cfn_ex23z1.htm	Edgar Link	pending
cfn_ex31z1.htm	Edgar Link	pending
cfn_ex32z1.htm	Edgar Link	pending
cnfn-20231231.htm	Edgar Link	pending
cnfn-20231231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
cnfn-20231231_def.xml	Edgar Link	unprocessable
cnfn-20231231_lab.xml	Edgar Link	unprocessable
cnfn-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cnfn-20231231_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cnfn-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNFN
CFN Enterprises Inc. Stock $cnfn

2024 Q2 Form 10-K Financial Statement

#000109690624000789 Filed on April 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN CFN Enterprises Inc. Stock $cnfn

2024 Q2 Form 10-K Financial Statement

#000109690624000789 Filed on April 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNFN
CFN Enterprises Inc. Stock $cnfn